An observational study in Juvenile Idiopathic Arthritis (JIA), Familial Mediterranean Fever (FMF ) and Healthy Controls, sponsored by Istanbul University - Cerrahpasa. Not yet recruiting. Open to participants aged 6 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-11-26.
Sponsored by Istanbul University - Cerrahpasa · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Arthritis, Juvenile by Istanbul University - Cerrahpasa — 6 open to participants now, 6 under way, none of them phase 3. Arthritis, Juvenile · Istanbul University - Cerrahpasa.
Among the 13 studies in Arthritis, Juvenile by Istanbul University - Cerrahpasa, this one is one of 6 that started in 2024, is one of 5 observational ones, and was the 9th registered.
365 studies on the registry are indexed under Arthritis, Juvenile; 101 are open to participants now.
Browse Arthritis, Juvenile studies →6 of the 13 studies in Arthritis, Juvenile by Istanbul University - Cerrahpasa are open now, in 1 country. Recruiting first, the newest first:
Istanbul University - Cerrahpasa · Sites in Turkey
Ages 8–12
Istanbul University - Cerrahpasa · Sites in Turkey
Ages 8–16 · Healthy volunteers
Istanbul University - Cerrahpasa · Sites in Turkey
Ages 13–18 · Healthy volunteers
Istanbul University - Cerrahpasa
Ages 10–18
Istanbul University - Cerrahpasa · Sites in Turkey
Ages 12–18
By country, each count listing its studies:
Of the 69 Arthritis, Juvenile studies recruiting now, 13 (19%) set no upper age limit and 50 (72%) stop at 75 or younger; 65 take children under 18; 11 take healthy volunteers.
This study: 6 Years to 18 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2020; this study’s year is marked. 6 started in 2024.
This study's planned enrollment of 60 is below the median of 120 across 118 observational studies indexed under Arthritis, Juvenile.
Median enrollment 35 across the 8 interventional studies, 70 across the 5 observational. Of the 7 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Istanbul University - Cerrahpasa is the lead sponsor of 701 studies on the registry; 211 are open to participants now.
None of the studies under way reaches primary completion within a year.
Among the 13 studies in Arthritis, Juvenile by Istanbul University - Cerrahpasa, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
In pediatric rheumatic diseases, joint swelling, effusion, tenderness, and painful restriction of joint movement, particularly in weight-bearing joints, frequently alter walking function. These changes affect temporal and spatial parameters of gait, as well as kinematic and kinetic characteristics, leading to functional limitations. Comprehensive physical assessments in patients may not always predict changes in gait parameters. Therefore, incorporating objective methods related to gait and balance into physical evaluations is essential for functional insights and clinical decision-making, aiming to prevent adaptive mechanisms that could negatively affect gait function in the long term. In this context, smart insoles have emerged as a new tool for gait analysis, offering an alternative to high-cost, lab-based equipment. The Digitsole Pro® system can measure gait profile and variables in real-life conditions. A review of the literature reveals no studies utilizing smart insole-based gait assessments in pediatric rheumatic patients. The aim of our study is to investigate the gait profile and variables of children and adolescents with pediatric rheumatic disease using the next-generation Digitsole Pro® smart insole system, and to compare the results with those of healthy peers.
Patients diagnosed with Juvenile Idiopathic Arthritis (JIA) and Familial Mediterranean Fever (FMF) who are being followed at the Istanbul Medical Faculty Pediatric Rheumatology Clinic will be included in the study. For the healthy control group, healthy children and adolescents without any illnesses who volunteer to participate in the study will be included.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Children and adolescents with pediatric rheumatic disease:
Healthy children and adolescents:
Exclusion Criteria:
Exclusion criteria for children and adolescents with pediatric rheumatic disease:
Exclusion criteria for healthy children and adolescents:
Patients diagnosed with JIA who are being followed at the Istanbul Medical Faculty Pediatric Rheumatology Clinic will be included in the study.
Patients diagnosed with FMF who are being followed at the Istanbul Medical Faculty Pediatric Rheumatology Clinic will be included in the study.
For the healthy control group, healthy children and adolescents without any illnesses who volunteer to participate in the study will be included.
Heel Strike Angle
Monopedal parameters of walking such as heel strike will be assessed with Digitsole Pro.
Time frame: Baseline
Heel-Off Angle
Monopedal parameters of walking such as heel-off will be assessed with Digitsole Pro.
Time frame: Baseline
Flat Foot
Monopedal parameters of walking such as Flat-Foot (FFI) will be assessed with Digitsole Pro.
Time frame: Baseline
Step Length
Monopedal parameters of walking such as step length in meters will be assessed with Digitsole Pro.
Time frame: Baseline
Stance Duration
Monopedal parameters of walking such as stance duration time will be assessed with Digitsole Pro.
Time frame: Baseline
Percentage of swing time
Monopedal parameters of walking such as percentage of swing time will be assessed with Digitsole Pro.
Time frame: Baseline
Cadance
Bipedal parameters of walking such as cadance will be assessed with Digitsole Pro.
Time frame: Baseline
Walking speed
Bipedal parameters of walking such as walking speed (km/h) will be assessed with Digitsole Pro.
Time frame: Baseline
Double Support Time
Bipedal parameters of walking such as double support time will be assessed with Digitsole Pro.
Time frame: Baseline
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Dec 2024; primary completion for Jan 2025, 1 month later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Istanbul University - Cerrahpasa →